241 related articles for article (PubMed ID: 8525129)
1. [Resistance of Mycobacterium tuberculosis in Mexican patients. I. Clinical features and risk factors].
Sifuentes-Osornio J; Ponce-de-León LA; Camacho-Mezquita FE; Bobadilla-del-Valle JM; Infante-Suárez ML; Ramírez-Fernández N; Hernández-Gómez L; Nelson AM
Rev Invest Clin; 1995; 47(4):273-81. PubMed ID: 8525129
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
[TBL] [Abstract][Full Text] [Related]
3. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda.
Joloba ML; Whalen CC; Cave DM; Eisenach KD; Johnson JL; Okwera A; Morrissey A; Bajaksouzian S; Feagin J; Mugerwa R; Ellner J; Jacobs MR
East Afr Med J; 2000 Feb; 77(2):111-5. PubMed ID: 10774085
[TBL] [Abstract][Full Text] [Related]
4. [Isolation of Mycobacterium tuberculosis with primary resistance to chemotherapeutic agents in patients with HIV infection].
Sesma P; Esteban J; Gegundez MI; Manrique A; Espinosa P; Fernández-Guerrero ML
Enferm Infecc Microbiol Clin; 1992; 10(7):416-20. PubMed ID: 1450261
[TBL] [Abstract][Full Text] [Related]
5. Drug-resistant tuberculosis in Taipei, 1996-1999.
Wang PD; Lin RS
Am J Infect Control; 2001 Feb; 29(1):41-7. PubMed ID: 11172317
[TBL] [Abstract][Full Text] [Related]
6. [Incidence of tuberculostatic-resistant Mycobacterium tuberculosis. Clinical aspects and impact on therapy and clinical course].
Esteban J; Gegúndez MI; García-Corbeira P; Soriano F
Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):415-9. PubMed ID: 8260512
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospital.
Weltman AC; Rose DN
Arch Intern Med; 1994 Oct; 154(19):2161-7. PubMed ID: 7944836
[TBL] [Abstract][Full Text] [Related]
8. The emergence of drug-resistant tuberculosis in New York City.
Frieden TR; Sterling T; Pablos-Mendez A; Kilburn JO; Cauthen GM; Dooley SW
N Engl J Med; 1993 Feb; 328(8):521-6. PubMed ID: 8381207
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia.
Alrajhi AA; Abdulwahab S; Almodovar E; Al-Abdely HM
Saudi Med J; 2002 Mar; 23(3):305-10. PubMed ID: 11938422
[TBL] [Abstract][Full Text] [Related]
10. Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.
Matee M; Mfinanga S; Holm-Hansen C
APMIS; 2009 Apr; 117(4):263-7. PubMed ID: 19338514
[TBL] [Abstract][Full Text] [Related]
11. Drug resistance among tuberculosis patients, New York City, 1991 and 1992.
Driver CR; Frieden TR; Bloch AB; Onorato IM
Public Health Rep; 1994; 109(5):632-6. PubMed ID: 7938383
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
[TBL] [Abstract][Full Text] [Related]
13. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
[TBL] [Abstract][Full Text] [Related]
14. Trends in Mycobacterium tuberculosis resistance, Pakistan, 1990-2007.
Hasan R; Jabeen K; Mehraj V; Zafar F; Malik F; Hassan Q; Azam I; Kadir MM
Int J Infect Dis; 2009 Nov; 13(6):e377-82. PubMed ID: 19369103
[TBL] [Abstract][Full Text] [Related]
15. [Resistance rates of Mycobacterium tuberculosis complex strains isolated from clinical specimens].
Aydın F; Kaklıkkaya N; Bayramoğlu G; Ozkul G; Buruk K; Dinç U; Köse T; Dede R
Mikrobiyol Bul; 2011 Jan; 45(1):36-42. PubMed ID: 21341157
[TBL] [Abstract][Full Text] [Related]
16. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
17. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
[TBL] [Abstract][Full Text] [Related]
18. A continuing survey of drug-resistant tuberculosis, New York City, April 1994.
Fujiwara PI; Cook SV; Rutherford CM; Crawford JT; Glickman SE; Kreiswirth BN; Sachdev PS; Osahan SS; Ebrahimzadeh A; Frieden TR
Arch Intern Med; 1997 Mar; 157(5):531-6. PubMed ID: 9066457
[TBL] [Abstract][Full Text] [Related]
19. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
20. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
Al-Marri MR
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]